ID193 Disparidades de preços em compras públicas e na saúde suplementar e o cosequente aumento das inequidades de acesso a medicamentos

ID193 Disparidades de preços em compras públicas e na saúde suplementar e o cosequente aumento das inequidades de acesso a medicamentos

Introdução O acesso a medicamentos inovadores e eficazes é uma preocupação central no sistema de saúde, tanto no âmbito público quanto privado. No contexto do Sistema Único de Saúde (SUS), a Comissão Nacional de Incorporação de Tecnologias (Conitec) desempenha um papel crucial na avaliação e rec...

Full description

Saved in:

Bibliographic Details
Main Authors:	Marcus Carvalho Borin, Mariana Michel Barbosa, Silvana Maria Bruschi Kelles.
Format:	Article
Language:	English
Published:	Instituto Nacional de Assistência Farmacêutica e Farmacoeconomia 2024-11-01
Series:	Jornal de Assistência Farmacêutica e Farmacoeconomia
Subjects:	Precificação; trastuzumabe; adalimumabe; Saúde Suplementar; ANS; CMED
Online Access:	https://ojs.jaff.org.br/ojs/index.php/jaff/article/view/1000
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

ID191 Impacto das Novas Indicações de trastuzumabe deruxtecano após Registro Inicial pela ANVISA
by: Marcus Carvalho Borin, et al.
Published: (2024-11-01)

ID018 Processo de análise das consultas públicas ao longo da atualização do Rol de Procedimentos e Eventos em Saúde da Agência Nacional de Saúde Suplementar
by: Rachel Riera, et al.
Published: (2024-11-01)

Percepção de gestores de Cooperativas de Trabalho acerca de práticas de controle contábil e gerencial para formação de preço de produtos artesanais
by: Paulo César dos Santos Silva, et al.
Published: (2024-12-01)

ID017 Apoio às ações de avaliação de tecnologias em saúde da agência nacional de saúde suplementar. Projeto PROADI-SUS, Hospital Sírio-Libanês
by: Rachel Riera, et al.
Published: (2024-11-01)

Existe o efeito liquidez no mercado acionário brasileiro?
by: Márcio André Veras Machado, et al.
Published: (2012-01-01)

ID189 Vulnerabilidade em Saúde: Repensando Estratégias de intervenção na Saúde Suplementar
by: Marcus Carvalho Borin, et al.
Published: (2024-11-01)

Âncoras de decisão: um estudo de precificação com produtos originais e réplicas
by: Jefferson Rodrigues Pereira, et al.
Published: (2015-07-01)

Adalimumab-induced optic neuropathy in a patient with Behçet’s syndrome
by: Sofia Miranda, et al.
Published: (2025-01-01)

Iraqi Registry Data Proves Safety and Efficacy of switching to Adalimumab Biosimilar in Treating Rheumatoid Arthritis
by: Yasameen Abbas, et al.
Published: (2024-12-01)

A prospective, randomized, double-blind, comparative clinical study of efficacy and safety of a biosimilar adalimumab with innovator product in patients with active rheumatoid arthritis on a stable dose of methotrexate
by: Prasad Apsangikar, et al.
Published: (2018-01-01)

Abandono afetivo: os limites do direito na coerção de manifestações emocionais humanas
by: Arthur M. Ferreira Neto, et al.
Published: (2015-01-01)

Tuberculosis of the tongue in a patient under treatment with adalimumab
by: Cintia Mussi Milani, et al.
Published: (2024-12-01)

Evaluating risk factors for Trastuzumab-Deruxtecan Pneumonitis in patients with metastatic breast cancer
by: Jonathan Henricks, et al.
Published: (2025-02-01)

ID200 Pharmaceutical Innovativeness Index (PII) como Estratégia de Precificação de Inovações Farmacêuticas: Estudo de Caso da Terapia Carvykti®
by: Ludmila Peres Gargano, et al.
Published: (2024-11-01)

Efficacy and safety of tofacitinib in an open-label, long-term extension study in patients with psoriatic arthritis who received adalimumab or tofacitinib in a Phase 3 randomized controlled study: a post hoc analysis
by: Dafna D. Gladman, et al.
Published: (2024-12-01)

Report of successful treatment of follicular occlusion triad with adalimumab and research progress on biologic therapy for follicular occlusion triad
by: Ruiling Jia, et al.
Published: (2024-12-01)

Involvement of HLADQA1*05 in Patients with Inflammatory Bowel Disease Treated with Anti-TNF Drugs
by: Anna Pau, et al.
Published: (2025-01-01)

ID188 A Experiência de Avaliação de Tecnologia em Saúde no Sistema de Saúde Suplementar Brasileiro
by: Marcus Carvalho Borin, et al.
Published: (2024-11-01)

Echocardiographic Assessment of Ventricular Cardiomyopathy in Patients with Breast Cancer under Trastuzumab Chemotherapy
by: Nakisa Khansari, et al.
Published: (2024-06-01)

Liquidez e precificação de ativos: evidências do mercado brasileiro
by: Márcio André Veras Machado, et al.
Published: (2014-01-01)

Olası Trastuzumab Kullanımına Bağlı Gelişen Pyojenik Granülom
by: Hilmi Cevdet Altınyazar, et al.
Published: (2013-01-01)

ID187 O Impacto do Registro Acelerado de Medicamentos pela Anvisa no Cenário Regulatório Brasileiro
by: Marcus Carvalho Borin, et al.
Published: (2024-11-01)

Adalimumab for endoscopic and histopathological mucosal healing in paediatric patients with moderate to severe Crohn’s disease
by: Edyta Szymanska, et al.
Published: (2016-12-01)

Outcome of cataract surgery in juvenile idiopathic arthritis-associated uveitis under two different biological regimens
by: Mariam R Fadel, et al.
Published: (2024-10-01)

Efficacy of adalimumab in noninfectious pediatric uveitis: Analysis of 29 eyes from a tertiary eye care center in India
by: Nida Khan, et al.
Published: (2024-12-01)

Trastuzumab emtansine in locally advanced or metastatic HER2 positive breast cancer; GENESIS-SEFH drug evaluation report
by: Patricia Miranda Romero, et al.
Published: (2015-02-01)

A Cost-Effective and Robust Cell-Based Bioassay Method for Evaluating the Bioactivity of Trastuzumab-like Antibodies
by: Pooja Bharali, et al.
Published: (2024-12-01)

Long-term stability of trastuzumab in plasma and whole blood samples stored under different conditions
by: Jonathan González-García, et al.
Published: (2019-03-01)

Superior effect of adalimumab versus secukinumab on ultrasound-confirmed synovitis in psoriatic arthritis: comprehensive evidence from musculoskeletal ultrasound and clinical assessments
by: Yiyi Wang, et al.
Published: (2024-12-01)

Rheumatoid arthritis associated cytokines and therapeutics modulate immune checkpoint receptor expression on T cells
by: Dana Emerson, et al.
Published: (2025-02-01)

Serum drug levels and anti-drug antibodies in the context of dose tapering by interval prolongation of adalimumab, etanercept and ustekinumab in psoriasis patients: results of the CONDOR trial
by: Selma Atalay, et al.
Published: (2022-07-01)

Successful treatment of pyoderma gangrenosum complicated by JAK2V617F mutation-positive myelofibrosis with adalimumab and systemic steroid
by: Kyohei Shibuta, et al.
Published: (2025-01-01)

Deep learning-based prediction of HER2 status and trastuzumab treatment efficacy of gastric adenocarcinoma based on morphological features
by: Zhida Wu, et al.
Published: (2025-01-01)

The Real-World Clinical Outcomes of Heavily Pretreated HER2+ and HER2-Low Metastatic Breast Cancer Patients Treated with Trastuzumab Deruxtecan at a Single Centre
by: Anna-Maria Lazaratos, et al.
Published: (2024-12-01)

Interventions for prevention and treatment of trastuzumab-induced cardiotoxicity: an umbrella review of systematic reviews and meta-analyses
by: Yunfang Wang, et al.
Published: (2024-12-01)

Lapatinib plus transtuzumab for HER-2 positiva metastatic breast cancer: Experience of use
by: C. García-Muñoz, et al.
Published: (2014-03-01)

Resistance mechanisms and prospects of trastuzumab
by: Lizhe Wang, et al.
Published: (2024-11-01)

Trastuzumab plus chemotherapy versus chemotherapy alone in HER2-positive gastric cancer treatment in Iran: a cost-effectiveness analysis
by: Sara Kaveh, et al.
Published: (2024-11-01)

Efficiency and safety of one-year anti-TNF-α treatment in Crohn’s disease: a Polish single-centre experience
by: Marcin Sochal, et al.
Published: (2019-12-01)

Crohn's disease-associated keratopathy: A case report
by: Ji Ho Kim, et al.
Published: (2024-12-01)